[1] Moschovakis GL, Forster R. Multifaceted activities of CCR7 regulate T-cell homeostasis in health and disease[J].Eur J Immunol, 2012, 42(8):1949-1955.
[2] Nandagopal S, Wu D, Lin F. Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields[J]. PLoS One, 2011, 6(3):e18183.
[3] Ziegler E, Oberbarnscheidt M, Bulfone-Paus S, et al. CCR7 signaling inhibits T cell proliferation[J]. J Immunol, 2007, 179(10):6485-6493.
[4] Sanchez-Sanchez N, Riol-Blanco L, Rodriguez-Fernandez JL. The multiple personalities of the chemokine receptor CCR7 in dendritic cells[J]. J Immunol, 2006, 176(9):5153-5159.
[5] Paniagua JA. Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome[J]. World J Diabetes, 2016, 7(19):483-514.
[6] Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance[J]. J Clin Invest, 2003, 112(12):1821-1830.
[7] Bullo M, Garcia-Lorda P, Megias I, et al. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression[J]. Obes Res, 2003, 11(4):525-531.
[8] Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue[J]. J Clin Invest, 2003, 112(12):1796-1808.
[9] Prieur X, Mok CY, Velagapudi VR, et al. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice[J]. Diabetes, 2011, 60(3):797-809.
[10] Deiuiis J, Shah Z, Shah N, et al. Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers[J]. PLoS One, 2011, 6(1):e16376.
[11] Hellmann J, Sansbury BE, Holden CR, et al. CCR7 maintains nonresolving lymph node and adipose inflammation in obesity[J]. Diabetes, 2016, 65(8):2268-2281.
[12] Forster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands:balancing immunity and tolerance[J]. Nat Rev Immunol, 2008, 8(5):362-371.
[13] Tian Y, Jiang C, Wang M, et al. BMI, leisure-time physical activity, and physical fitness in adults in China:results from a series of national surveys, 2000-14[J]. Lancet Diabetes Endocrinol, 2016, 4(6):487-497.
[14] Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity[J]. Annu Rev Immunol, 2011, 29(29):415-445.
[15] Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance[J]. J Clin Invest, 1995, 95(5):2409-2415.
[16] Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance[J]. J Clin Invest, 2006, 116(7):1793-1801.
[17] Han JM, Levings MK. Immune regulation in obesity-associated adipose inflammation[J]. J Immunol, 2013, 191(2):527-532.
[18] Deng T, Lyon CJ, Bergin S, et al. Obesity, inflammation, and cancer[J]. Annu Rev Pathol, 2016, 11:421-449.
[19] Milanski M, Degasperi G, Coope A, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus:implications for the pathogenesis of obesity[J]. J Neurosci, 2009, 29(2):359-370.
[20] Shi H, Kokoeva MV, Inouye K, et al. TLR4 links innate immunity and fatty acid-induced insulin resistance[J]. J Clin Invest, 2006, 116(11):3015-3025.
[21] Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes:defining their role in the development of insulin resistance and beta-cell dysfunction[J]. Eur J Clin Invest, 2002, 32(Suppl 3):14-23.
[22] Iyer A, Fairlie DP, Prins JB, et al. Inflammatory lipid mediators in adipocyte function and obesity[J]. Nat Rev Endocrinol, 2010, 6(2):71-82.
[23] Salvado L, Coll T, Gomez-Foix AM, et al. Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism[J]. Diabetologia, 2013, 56(6):1372-1382.
[24] Gadang V, Kohli R, Myronovych A, et al. MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched diet[J]. Am J Physiol Endocrinol Metab, 2013, 305(4):E549-556.
[25] Ordelheide AM, Gommer N, Bohm A, et al. Granulocyte colony-stimulating factor (G-CSF):A saturated fatty acid-induced myokine with insulin-desensitizing properties in humans[J]. Mol Metab, 2016, 5(4):305-316.
[26] Lee HS, Park JH, Kang JH, et al. Chemokine and chemokine receptor gene expression in the mesenteric adipose tissue of KKAy mice[J]. Cytokine, 2009, 46(2):160-165.
[27] Tourniaire F, Romier-Crouzet B, Lee JH, et al. Chemokine expression in inflamed adipose tissue is mainly mediated by NF-kappaB[J]. PLoS One, 2013, 8(6):e66515.
[28] Kitahara CM, Trabert B, Katki HA, et al. Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance[J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(12):2840-2849.
[29] Sano T, Iwashita M, Nagayasu S, et al. Protection from diet-induced obesity and insulin resistance in mice lacking CCL19-CCR7 signaling[J]. Obesity (Silver Spring), 2015, 23(7):1460-1471.
[30] Cho KW, Zamarron BF, Muir LA, et al. Adipose tissue dendritic cells are independent contributors to obesity-induced inflammation and insulin resistance[J]. J Immunol, 2016, 197(9):3650-3661.
[31] Stefanovic-Racic M, Yang X, Turner MS, et al. Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver[J]. Diabetes, 2012, 61(9):2330-2339.
[32] Bertola A, Ciucci T, Rousseau D, et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients[J]. Diabetes, 2012, 61(9):2238-2247.
[33] Xu X, Grijalva A, Skowronski A, et al. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation[J]. Cell Metab, 2013, 18(6):816-830.
[34] Orr JS, Kennedy AJ, Hill AA, et al. CC-chemokine receptor 7(CCR7) deficiency alters adipose tissue leukocyte populations in mice[J]. Physiol Rep, 2016, 4(18):e12971.
[35] Suganami T, Yuan X, Shimoda Y, et al. Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated Fatty acid/toll-like receptor 4 signaling and macrophage activation in obese adipose tissue[J]. Circ Res, 2009, 105(1):25-32.
[36] Morris DL, Cho KW, Delproposto JL, et al. Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice[J]. Diabetes, 2013, 62(8):2762-2772.
[37] Cho KW, Morris DL, Delproposto JL, et al. An MHC Ⅱ-dependent activation loop between adipose tissue macrophages and CD4+ T cells controls obesity-induced inflammation[J]. Cell Rep, 2014, 9(2):605-617.
[38] Keshel TE, Coker RH. Exercise training and insulin resistance:a current review[J]. J Obes Weight Loss Ther, 2015, 5(Suppl 5):S5-L3.
[39] Reyna SM, Ghosh S, Tantiwong P, et al. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects[J]. Diabetes, 2008, 57(10):2595-2602.
[40] Kawanishi N, Yano H, Mizokami T, et al. Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice[J]. Brain Behav Immun, 2012, 26(6):931-941.
[41] Wasinski F, Bacurau RF, Moraes MR, et al. Exercise and caloric restriction alter the immune system of mice submitted to a high-fat diet[J]. Mediators Inflamm, 2013, 2013:395672.
[42] Kawanishi N, Mizokami T, Yano H, et al. Exercise attenuates M1 macrophages and CD8+ T cells in the adipose tissue of obese mice[J]. Med Sci Sports Exerc, 2013, 45(9):1684-1693.
[43] Nickel T, Hanssen H, Emslander I, et al. Immunomodulatory effects of aerobic training in obesity[J]. Mediators Inflamm, 2011, 2011:308965. |
